Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

NCT02583685 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG: PR4 + LDV/SOF + ASV 4 wk
DRUG: PR4 + LDV/SOF + SMV 4 wk
DRUG: PR4 + LDV/SOF + ASV 6 wk
DRUG: PR4 + LDV/SOF + SMV 6 wk
DRUG: PR4 + LDV/SOF + ASV 8 wk
DRUG: PR4 + LDV/SOF + SMV 8 wk
DRUG: PR4 + LDV/SOF + ASV 12 wk
DRUG: PR4 + LDV/SOF + SMV 12 wk

Sponsor

Humanity and Health Research Centre

Collaborators

[object Object]
[object Object]